ArticleFrontiers in medicine2025
Time series forecasting of red blood cell demand in hematology patients using SARIMA and exponential smoothing models: a retrospective analysis in a Chinese tertiary hospital.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI and Blood Banking: Predicting Transfusion Demand - A Systematic Review of Forecasting Approaches.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Red blood cells (RBCs) infusion is very important for the treatment of hematology patients, but how to maintain a balanced state between the supply and demand of RBCs is still a major challenge. Objective: This study aimed to explore the feasibility of seasonal autoregressive integrated moving average (SARIMA) model and exponential smoothing (ES) model in predicting the clinical demand of RBCs for hematology patients each month. Methods: Our study collected the monthly RBCs usage data of hematology patients from January 2014 to December 2023 to establish the SARIMA model and ES model, respectively. Then, the optimal model was used to forecast the monthly usage of RBCs from January to June 2024, and we subsequently compared the data with actual values to evaluate the prediction effect of the model. Results: The best fitting SARIMA model was SARIMA (2,1,0)(1,1,1) Conclusion: Compared with the ES model, the SARIMA model has a smaller mean relative error in predicting RBCs usage in hematology patients. DM test also verify this result. But in the future, more similar research data are needed to make research more convincing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.